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Abstract 
Background: Health facility-based data reported through routine health information systems form the primary data 
source for programmatic monitoring and evaluation in most developing countries. The adoption of District Health 
Information Software (DHIS2) has contributed to improved availability of routine health facility-based data in many 
low-income countries. An assessment of malaria indicators data reported by health facilities in Kenya during the first 
5 years of implementation of DHIS2, from January 2011 to December 2015, was conducted.
Methods: Data on 19 malaria indicators reported monthly by health facilities were extracted from the online Kenya 
DHIS2 database. Completeness of reporting was analysed for each of the 19 malaria indicators and expressed as the 
percentage of data values actually reported over the expected number; all health facilities were expected to report 
data for each indicator for all 12 months in a year.
Results: Malaria indicators data were analysed for 6235 public and 3143 private health facilities. Between 2011 and 
2015, completeness of reporting in the public sector increased significantly for confirmed malaria cases across all 
age categories (26.5–41.9%, p < 0.0001, in children aged <5 years; 30.6–51.4%, p < 0.0001, in persons aged ≥5 years). 
Completeness of reporting of new antenatal care (ANC) clients increased from 53.7 to 70.5%, p < 0.0001). Complete-
ness of reporting of intermittent preventive treatment in pregnancy (IPTp) decreased from 64.8 to 53.7%, p < 0.0001 
for dose 1 and from 64.6 to 53.4%, p < 0.0001 for dose 2. Data on malaria tests performed and test results were not 
available in DHIS2 from 2011 to 2014. In 2015, sparse data on microscopy (11.5% for children aged <5 years; 11.8% 
for persons aged ≥5 years) and malaria rapid diagnostic tests (RDTs) (8.1% for all ages) were reported. In the pri-
vate sector, completeness of reporting increased significantly for confirmed malaria cases across all age categories 
(16.7–23.1%, p < 0.0001, in children aged <5 years; 19.4–28.6%, p < 0.0001, in persons aged ≥5 years). Completeness 
of reporting also improved for new ANC clients (16.2–23.6%, p < 0.0001), and for IPTp doses 1 and 2 (16.6–20.2%, 
p < 0.0001 and 15.5–20.5%, p < 0.0001, respectively). In 2015, less than 3% of data values for malaria tests performed 
were reported in DHIS2 from the private sector.
Conclusions: There have been sustained improvements in the completeness of data reported for most key malaria 
indicators since the adoption of DHIS2 in Kenya in 2011. However, major data gaps were identified for the malaria-
test indicator and overall low reporting across all indicators from private health facilities. A package of proven DHIS2 
implementation interventions and performance-based incentives should be considered to improve private-sector 
data reporting.
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Background
Reliable health data are essential for health planners 
and programme implementers to make informed deci-
sions about resource allocations to prevent morbidity 
and mortality [1]. Historically, population-based health 
surveys have been conducted periodically to collect ret-
rospective data to inform planning and policy needs [2]. 
However, nationally representative health surveys are 
expensive, infrequent and might not reflect the current 
situation, particularly in a dynamic health environment. 
By contrast, health facility-based data are collected on a 
routine basis and have the potential to present more real-
time data for decision making, allowing disease control 
programmes to direct interventions in a more timely 
manner [2]. Health facility-based data reported through 
routine health information systems form the primary 
data source for national health planning, health surveil-
lance and programmatic monitoring and evaluation in 
most developing countries [3, 4]. Escalation of malaria 
control activities in Africa has led to increased demand 
for more robust data to track changes in transmission 
patterns and to develop interventions targeted to local 
heterogeneous conditions [5]. Routine data from health 
systems is critical for the design and implementation of 
malaria control programmes so that resources can be tar-
geted to the populations and areas that are most in need 
[6]. However, the quality of routine data has often been 
poor with a general lack of timeliness, completeness and 
accuracy [7–11]. The lack of quality data has resulted in 
challenges in using routine data to monitor and evaluate 
health interventions [12–14]. The World Health Organi-
zation (WHO) relies on modelling to estimate malaria 
morbidity and mortality trends in most countries in the 
African region due to incomplete routine data [15, 16]. 
However, the situation is now changing in many coun-
tries due to increased recognition of the importance of 
robust routine data to accurately track health progress 
and rapid developments in information technology [5, 
17].
The adoption of innovative, free and open source web-
based reporting software such as the District Health 
Information Software 2 (DHIS2) has contributed to 
improved availability of routine health facility-based 
data in many developing countries [4, 18–21]. Follow-
ing successful customization, testing and piloting, Kenya 
adopted DHIS2 as the routine health data reporting plat-
form in 2011 [22]. The current online DHIS2 database is 
structured by administrative units with individual health 
facilities assigned to 299 sub-counties and 47 counties. 
Health facilities report monthly data on diseases, com-
modities and service delivery through DHIS2. Data are 
collected through a paper-based system of registers, tally 
sheets, and monthly data reporting forms at each health 
facility. Due to poor internet connectivity and lack of 
infrastructure in most rural health facilities, the collated 
monthly data are sent to the sub-county level where they 
are entered into the web-based DHIS2 [21]. The software 
captures and remotely stores facility-level data by month 
and can generate quarterly or yearly reports by different 
administrative levels. The data entered and stored into 
the system are available to registered users and other 
stakeholders through a password protected log-in sys-
tem. Reporting rates for outpatient data have increased 
substantially since the introduction of DHIS2, and the 
system has high acceptance and utilization by stakehold-
ers [21–23].
In Kenya, malaria accounts for approximately 18% of 
outpatient visits at health facilities [24]. Clinical and con-
firmed malaria cases encountered in outpatient clinics are 
reported via DHIS2. The DHIS2 data repository contains 
substantial numbers of malaria cases reported across all 
health facilities in Kenya. However, routine surveillance 
reports published by the National Malaria Control Pro-
gramme (NMCP) have consistently shown anomalies in 
data reported via DHIS2 [25–31]. A nationally-represent-
ative, health facility-based survey that tested outpatients 
with suspected malaria in October and November 2014 
found no confirmed malaria cases at 47% of the surveyed 
facilities [32]. However, confirmed malaria cases were 
reported in routine DHIS2 at the same facilities during 
the same time period [32]. In order to fully utilize routine 
malaria surveillance data for policy and programming 
decisions, the NMCP and stakeholders must have confi-
dence in the data. The quality of data reported via DHIS2 
during the first 5 years of implementation, from January 
2011 to December 2015, was evaluated through an analy-
sis of completeness of 19 malaria indicators reported 
monthly by health facilities.
Methods
Nineteen malaria data indicators reported monthly 
by health facilities were extracted from the DHIS2 
online database [33] in February 2016. These included 
total number of clinical and confirmed malaria cases, 
artemether–lumefantrine (AL) treatments, intermit-
tent preventive treatment in pregnancy (IPTp) with sul-
fadoxine–pyrimethamine doses, long-lasting insecticidal 
bed nets (LLINs) distributed via antenatal care (ANC) 
and children health clinics and malaria tests performed 
(Table  1). Monthly data were extracted separately for 
each sub-county, disaggregated by health facility and 
arranged chronologically. The assembled sub-county data 
sets were merged into one database for the country.
Completeness of indicator data reporting was 
expressed as the percentage of data values actually 
reported over the expected number given that all health 
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facilities were expected to report each indicator for all 
12 months in a year. Completeness of reporting was cal-
culated by summing up the number of months with a 
data value reported for a given indicator across all health 
facilities in a year and dividing by the expected num-
ber of values (i.e., 12  months ×  total number of health 
facilities). All blank data fields were considered to be 
unreported data. Analysis was performed separately for 
public and private facilities and by epidemiological zones 
representing malaria transmission risk (i.e., the endemic 
zones of stable malaria around Lake Victoria and coast 
regions; the seasonal-transmission zone in the arid and 
semi-arid areas of northern and south-eastern regions; 
the highland epidemic-prone zone of the western region; 
and low-risk zone in the central highlands including Nai-
robi) [23].
Analysis of completeness of reporting of IPTp doses 
given to pregnant women was restricted to 1490 public 
and 709 private health facilities located in 14 counties 
in the lake-and coast-endemic zones. The analysis was 
restricted because the intervention is targeted only to 
HIV-negative women living in areas of moderate-to-high 
malaria transmission [23, 34]. Similarly, analysis of com-
pleteness of reporting of LLINs distributed was restricted 
to 4793 public and 2336 private health facilities located 
in 36 counties targeted for routine distribution of nets 
through ANC and child health clinics. Analysis of com-
pleteness of malaria testing indicators was only reported 
for 2015 because data for previous years were not availa-
ble. The change in indicator data reporting completeness 
over time is presented as a percentage-point increase or 
decrease in data values reported in 2015 compared to 
2011 except for artemether–lumefantrine (AL) treatment 
indicators for which 2012 was used as the baseline year 
due to limited data reported in 2011. The percentage of 
health facilities in the public sector that reported data for 
each indicator for all 12 months in a year was also deter-
mined. All data were cleaned and analysed in Excel 2013 
(Microsoft Corporation, Seattle, WA) and Stata version 
12 (StataCorp, College Station, TX).
Results
Description of health facilities analysed
Data were extracted from all 10,090 health facilities reg-
istered in the DHIS2 online database at the time of the 
study. During data cleaning, a total of 712 health facilities 
were excluded from analysis; 544 were health facilities 
that offered specialized services, 93 were duplicated facil-
ities due to multiple spellings for the same health facil-
ity, 39 were unclassified facilities (i.e., facility type and 
managing authority not specified), and 36 were reporting 
units representing aggregated data from several facilities 
already included. Data were therefore analysed for 9378 
(92.9%) of the health facilities registered in DHIS2 at the 
time of the study. Of these facilities, 6235 (66.5%) were 
public and 3143 (33.5%) were private (Table 2).
Completeness of data reported in public health facilities
Within the public sector, the percentage of data values 
reported for confirmed malaria cases increased in chil-
dren aged <5 years (26.5–41.9%, p < 0.0001) and in per-
sons aged ≥5  years (30.6–51.4%, p  <  0.0001) (Table  3). 
Table 1 List of  malaria indicators assessed in  the Kenya 
District Health Information Software 2
ANC antenatal care, IPTp intermittent preventive treatment in pregnancy with 
sulfadoxine–pyrimethamine, RDT rapid diagnostic test
a Limited to 14 counties where malaria transmission is moderate-to-high
b Limited to 36 counties where nets are routinely distributed
c RDT indicators were not reported by age category
Data indicators
Number of malaria cases
 Number of clinical malaria cases in children <5 years
 Number of clinical malaria cases in persons ≥5 years
 Number of confirmed malaria cases in children <5 years
 Number of confirmed malaria cases in persons ≥5 years
Artemether–lumefantrine treatments
 Number of patients treated with AL weight band 5–14 kg
 Number of patients treated with AL weight band 15–24 kg
 Number of patients treated with AL weight band 25–34 kg
 Number of patients treated with AL weight band ≥35 kg
Antenatal care and  IPTpa
 Number of new ANC clients
 Number of ANC clients who received first dose of IPTp
 Number of ANC clients who received second dose of IPTp
Long-lasting insecticidal bed  netsb
 Number of LLINs distributed at ANC clinics
 Number of LLINs distributed at child health clinics
Diagnostic test indicators
 Number of malaria blood slides examined in children <5 years
 Number of malaria blood slides examined in persons ≥5 years
 Number of positive malaria blood slides in children <5 years
 Number of positive malaria blood slides in persons ≥5 years
 Number of malaria RDTs  examinedc
 Number of positive malaria  RDTsc
Table 2 Description of health facilities by type and sector
Facility type (N = 9378) Public Private
n % n %
Dispensaries and clinics 4776 76.6 2932 93.3
Health centres 1032 16.6 61 1.9
Hospitals 427 6.8 150 4.8
Total 6235 66.5 3143 33.5
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Conversely, the percentage of data values reported for 
clinical (i.e., non-confirmed) malaria cases decreased in 
children aged <5  years (55.6–27.0%, p  <  0.0001) and in 
persons aged ≥5  years (56.4–30.3%, p  <  0.0001). There 
were small but significant declines in the percentage of 
data values reported for patients treated with the dif-
ferent AL treatment weight bands (declines ranged 
from 3.0% for AL ≥35 kg (adult dosing) to 7.6% for AL 
15–24 kg (pediatric dosing). The percentage of data val-
ues reported for new ANC clients increased (53.6–70.3%, 
p < 0.0001) while data values reported for IPTp doses in 
the 14 targeted counties decreased by 11%, p  <  0.0001. 
In the 36 counties targeted for routine distribution of 
LLINs, the percentage of data values reported for LLINs 
distributed via ANC clinics increased from 47.1 to 61.6% 
(p  <  0.0001) and via child health clinics from 20.3 to 
41.5% (p  <  0.0001). In 2015, sparse malaria testing data 
were reported for microscopy (11.5% for children aged 
<5  years; 11.8% for persons aged ≥5  years) and RDT 
(8.1% for all ages). Completeness of reporting based on 
the percentage of public health facilities that reported 
data on each indicator for all 12  months each year was 
much lower overall although the trends were similar to 
those presented in Table 3 (Additional file 1).
Analysis by malaria-risk zones showed significant 
increases in the percentage of data values reported for 
confirmed malaria cases in all except the low-risk zone 
(Fig.  1). The increase was highest in the lake-endemic 
zone (38–84% in children aged <5 years, p < 0.0001 and 
41–86% in persons aged ≥5 years, p < 0.0001). The per-
centage of data values reported for clinical malaria cases 
declined significantly across all zones. The decline was 
Table 3 Percentage of malaria indicator data values reported by public health facilities through the District Health Infor-
mation Software 2 in Kenya, 2011–2015
AL artemether–lumefantrine, ANC antenatal care, IPTp intermittent preventive treatment in pregnancy with sulfadoxine–pyrimethamine, LLINs long-lasting insecticidal 
bed nets, RDT rapid diagnostic test
a Analysis was restricted to 1490 health facilities in the lake-and coast-endemic zones where the IPTp intervention was targeted
b Analysis was restricted to 4793 health facilities in 36 counties targeted for routine distribution of LLINs
c Data only available for 2015
d RDT data not reported by age category
Malaria indicators Percentage of data values reported by year % point change p value
2011 2012 2013 2014 2015
Malaria cases
 Confirmed malaria (<5 years) 26.5 30.2 37.9 38.5 41.9 15.4 0.0001
 Confirmed malaria (≥5 years) 30.6 35.9 45.5 46.8 51.4 20.8 0.0001
 Clinical malaria (<5 years) 55.6 58.9 46.5 42.5 27.0 −28.6 0.0001
 Clinical malaria (≥5 years) 56.4 60.9 49.4 45.6 30.3 −26.0 0.0001
Artemether–lumefantrine treatments
 AL weight band 5–14 kg 37.3 35.9 30.7 30.8 −6.5 0.0001
 AL weight band 15–24 kg 35.2 33.5 30.0 27.6 −7.6 0.0001
 AL weight band 25–34 kg 32.7 29.3 26.1 28.2 −4.5 0.0001
 AL weight band ≥35 kg 37.6 37.5 32.0 34.6 −3.0 0.0001
Antenatal care and IPTp
 New ANC clients 53.7 61.5 64.8 67.7 70.5 16.8 0.0001
 IPTp dose  1a 64.8 69.5 72.2 72.9 53.7 −11.1 0.0001
 IPTp dose  2a 64.6 69.2 72.2 72.5 53.3 −11.3 0.0001
Long-lasting insecticidal bed  netsb
 LLINs via ANC clinics 47.1 45.0 55.7 57.3 61.6 14.5 0.0001
 LLINs via child health clinics 20.3 38.5 46.7 42.8 41.5 21.2 0.0001
Diagnostic test  indicatorsc
 Blood slide tested (<5 years) 0.0 0.0 0.0 0.1 11.5
 Blood slide positive (<5 years) 0.0 0.0 0.0 0.1 8.5
 Blood slide tested (≥5 years) 0.0 0.0 0.0 0.1 12
 Blood slide positive (≥5 years) 0.0 0.0 0.0 0.1 9.4
 RDT  testedd 0.0 0.0 0.0 0.0 8.1
 RDT  positived 0.0 0.0 0.0 0.0 5.4
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greatest in the coast-endemic zone (62–19%, p < 0.0001 
in children aged <5  years; 64–22%, p  <  0.0001 in per-
sons aged ≥5  years) and lowest in the highland epi-
demic-prone zone (62–52%, p < 0.0001 in children aged 
<5 years; 63–56%, p < 0.0001 in persons aged ≥5 years). 
Concurrent with a decrease in reporting of clinical 
malaria cases, the percentage of data values reported for 
the four AL treatment weight bands declined in all except 
the lake-endemic zone. The decreases were greatest in 
the low-risk zone (ranging from 15 to 20% decreases, all 
p < 0.0001) and smallest in the highland epidemic-prone 
zone (ranging from 2 to 4% decreases, all p < 0.0001) for 
all treatment weight bands. The percentage of data val-
ues reported for new ANC clients increased in all zones 
from 2011 to 2015 (range; 11 to 19%, p < 0.0001 for all). 
Reporting of LLINs distributed through ANC and child 
health clinics increased across all zones. The largest 
increase was in the lake-endemic zone with 21 and 36% 
increase for LLINs distributed via ANC and child health 
clinics, respectively (p < 0.0001 for both).
Table 4 Percentage of malaria data values reported by private health facilities through the District Health Information 
Software 2 in Kenya, 2011–2015
AL artemether–lumefantrine, ANC antenatal care, IPTp intermittent preventive treatment in pregnancy with sulfadoxine–pyrimethamine, LLINs long-lasting insecticidal 
bed nets, RDT rapid diagnostic test
a Analysis was restricted to 709 private health facilities in the lake-and coast-endemic zones where the IPTp intervention was targeted
b Analysis was restricted to 2366 private health facilities in 36 counties targeted for routine distribution of LLINs
c Data only available for 2015
d RDT data not reported by age category
Malaria indicators Percentage of data values reported by year % point change p value
2011 2012 2013 2014 2015
Malaria cases
 Confirmed malaria (<5 years) 16.7 20.3 20.2 23.2 23.1 6.4 0.0001
 Confirmed malaria (≥5 years) 19.4 24.0 24.1 28.0 28.6 9.2 0.0001
 Clinical malaria (<5 years) 20.6 25.0 20.5 19.8 15.0 −5.6 0.0001
 Clinical malaria (≥5 years) 22.4 27.3 22.7 22.1 17.7 −4.7 0.0001
Artemether–lumefantrine treatments
 AL weight band 5–14 kg 0.4 0.7 0.8 0.8 0.4 0.0001
 AL weight band 15–24 kg 0.4 0.7 0.8 0.7 0.3 0.0001
 AL weight band 25–34 kg 0.3 0.5 0.7 0.7 0.4 0.0001
 AL weight band ≥35 kg 0.4 0.8 1.0 0.9 0.5 0.0001
Antenatal care and IPTp
 New ANC clients 16.2 20.6 20.1 22.9 23.6 7.5 0.0001
 IPTp1a 16.6 19.5 22.0 22.1 20.2 3.6 0.0001
 IPTp2a 15.5 18.4 21.2 22.0 20.5 5.0 0.0001
Long-lasting insecticidal bed  netsb
 LLINs via ANC clinics 7.9 7.6 9.2 9.9 11.0 3.1 0.0001
 LLINs via child health clinics 3.0 6.2 7.8 6.8 6.8 3.8 0.0001
Diagnostic test  indicatorsc
 Blood slide tested (<5 years) 0.0 0.0 0.0 0.0 2.9
 Blood slide positive (<5 years) 0.0 0.0 0.0 0.0 2.1
 Blood slide tested (≥5 years) 0.0 0.0 0.0 0.0 3.5
 Blood slide positive (≥5 years) 0.0 0.0 0.0 0.0 2.9
 RDT  testedd 0.0 0.0 0.0 0.0 1.0
 RDT  positived 0.0 0.0 0.0 0.0 0.7
(See figure on previous page.) 
Fig. 1 Percentage of malaria data values submitted by public health facilities to District Health Information Software 2 in Kenya by transmission 
zones, 2011–2015. AL artemether–lumefantrine, ANC antenatal care, CHC child health clinic, IPTp intermittent preventive treatment in pregnancy 
with sulfadoxine–pyrimethamine (IPTp intervention is only targeted in the lake-and coast-endemic zones), LLINs long-lasting insecticidal bed nets
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Completeness of data reported in private health facilities
Overall, analysis of data reporting completeness from 
private health facilities showed trends that were similar 
to those seen in the public sector. However, the com-
pleteness of reporting in 2015 compared to 2011 was 
much lower for all indicators in private health facili-
ties compared to public health facilities (Table 4; Fig. 2). 
A significant increase was observed in the percent-
age of data values reported for confirmed malaria cases 
across all ages (16.7–23.1%, p  <  0.0001, in children 
aged <5  years; 19.4–28.6%, p  <  0.0001, in persons aged 
≥5  years). Other significant increases were observed in 
data values reported for new ANC clients (16.2–23.6%, 
p < 0.0001) and LLINs distributed via ANC (7.9–11.0%, 
p < 0.0001) and child health clinics (3.0–6.8%, p < 0.0001) 
(Table 4). Less than 1% of data values for AL treatment 
weight bands were reported by private health facilities 
for any given year. Less than 3% of data values for malaria 
testing indicators were reported by private health facili-
ties in 2015. Analysis by malaria-risk zones showed that 
the largest increase in confirmed malaria cases report-
ing was in the lake-endemic zone (27–51%, p < 0.0001, in 
children aged <5  years; 30–56%, p  <  0.0001, in persons 
aged ≥5 years). Clinical malaria reporting declined in all 
zones (p < 0.0001 for all). Reporting of new ANC clients 
increased by 7–8% across all zones (p  <  0.0001 for all) 
(Fig. 2).
Discussion
Routine malaria data for 19 indicators reported via the 
Kenya DHIS2 were assessed for completeness from 
2011 to 2015. The assessment showed improvements 
in both national and sub-national reporting complete-
ness for malaria indicator data over the first 5  years of 
DHIS2 implementation in Kenya. Completeness of data 
reporting in the public sector was much higher than in 
the private sector. Improvements in reporting complete-
ness in the public sector may be attributed to substan-
tial infrastructure and human resource investments for 
DHIS2 implementation including longitudinal train-
ing and support [22]. In addition, the public sector has 
higher demands for data to meet the reporting require-
ments of external donors and forecast commodity needs. 
For example, DHIS2 data fulfils the Global Fund to Fight 
AIDS, Tuberculosis and Malaria grant reporting require-
ments and informs forecasting for commodity procure-
ments including RDTs, AL and LLINs [35]. The higher 
demand for and use of public sector health data has also 
led to additional disease-specific investments to improve 
reporting.
Private-sector facilities, in contrast, do not rely on 
donor-funded commodities, and the demand for data 
from external users is low. Kenya, however, has a large 
and robust private health sector comprising half of all 
health facilities [36]. In 2015, 25% of children who had a 
fever in the 2 weeks preceding a large household malaria 
survey sought treatment from private health facilities 
[37]. The private sector would be a rich source of malaria 
data and increase the generalizability of national and sub-
national trends if reported. The Kenya Malaria Strategy 
recognizes the contribution of the private sector in pro-
viding care for malaria patients [23]. The NMCP pro-
vides support to the private sector primarily through 
the Affordable Medicines Facility-malaria to increase 
the affordability and availability of quality-assured AL 
via subsidies but also through malaria case management 
trainings [23]. However, data reporting from private 
health facilities remains poor because there is little incen-
tive to report and no enforcement of the data reporting 
policy [38]. Providing a DHIS2 implementation package 
to private sector health facilities that includes training, 
standardized reporting tools and software support might 
have a similar positive impact as realized in the public 
sector. Performance-based incentives might also be con-
sidered; private health facilities are likely to be motivated 
by facility-based incentive programmes that give them an 
opportunity to earn additional resources [39].
A major limitation of the malaria indicator data was the 
inability to distinguish true missing values (i.e., no data 
reported) from ‘zero’ values (i.e., no events captured) 
because both scenarios appeared as blank data entries in 
DHIS2. Health facilities in Kenya do not usually report 
‘zero’ values when no events are captured. All blank 
data entries were, therefore, classified as missing (i.e., no 
data reported). As a result, the completeness of report-
ing observed likely under-represented the true situa-
tion. For example, in low-risk and seasonal-transmission 
zones, the majority of health facilities did not report con-
firmed malaria cases. Based on the very low prevalence of 
malaria in these zones, it is probable that the majority of 
health facilities diagnosed zero confirmed malaria cases 
for at least some months of the year, which is consistent 
with findings from a recent health-facility survey [32]. 
Currently in DHIS2, facilities with no confirmed malaria 
(See figure on previous page.) 
Fig. 2 Percentage of malaria data values submitted by private health facilities to District Health Information Software 2 in Kenya by transmission 
zones, 2011–2015. AL artemether–lumefantrine, ANC antenatal care, CHC child health clinic, IPTp intermittent preventive treatment in pregnancy 
with sulfadoxine–pyrimethamine (IPTp intervention is only targeted in the lake-and coast-endemic zones), LLINs long-lasting insecticidal bed nets
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cases that do not report a ‘zero’ value and facilities that 
diagnose malaria cases but do not report both show 
blank fields. DHIS2 should require data fields for key 
malaria indicators to be filled in using conditional rules 
requiring input of an integer value including ‘zero’ and 
unfilled fields defaulting to ‘NDR’ (i.e., no data reported) 
or another coded value prior to data submission.
The relationship between program implementation 
and reporting is also critical to the interpretation of 
surveillance data and related to zero-reporting. With-
out zero-reporting, it is impossible to determine from 
malaria-indicator data alone if a program service or 
commodity is not delivered, not reported or both. For 
example, despite over 90% of public sector health facili-
ties having diagnostic capacity and approximately 40% 
reporting confirmed malaria cases in 2013, none reported 
diagnostic testing data via DHIS2 in 2013 [40]. This is an 
example of service delivery but no reporting via DHIS2. 
Although completeness of reporting does not necessar-
ily reflect programme implementation, facilities have 
incentive to report when the data drives actions such as 
malaria commodity procurements and deliveries.
Analysis by malaria-risk zones showed that the lake-
endemic zone had the greatest reporting completeness 
improvements for confirmed malaria cases, AL treat-
ments, and LLINs distributed via ANC and child health 
clinics. Because the majority of malaria cases are in the 
lake-endemic zone, the NMCP and key partners have 
focused malaria prevention and control interventions 
in the eight counties located in this zone since 2013 
[41]. Improvements in malaria indicator data reporting 
completeness are likely a result of substantial malaria 
and other disease programming investments, including 
strengthening supply chain management for commodi-
ties and surveillance, in the zone [41].
Overall, there were significant increases in complete-
ness of reporting of confirmed malaria cases, new ANC 
clients, and LLIN distribution via ANC and child health 
clinics in both the public and private sectors while data 
values reported for clinical malaria cases declined. The 
increase in reporting completeness of confirmed malaria 
cases was probably related to the national expansion of 
malaria RDTs. In late 2012, the NMCP implemented 
policy to distribute malaria RDTs to all public sector 
health facilities in Kenya. CareStart Malaria histidine-
rich protein 2 (HRP2) Plasmodium falciparum RDTs 
were supplied to all health facilities through the Kenya 
Medical Supplies Agency [25]. Consequently, the per-
centage of public sector health facilities with functional 
capacity to diagnose malaria increased from 59% in 
2011 to 97% by the end of 2015 [40]. However, despite 
significant improvements, the assessment found that 
the highland epidemic-prone zone continued to report 
a relatively high percentage of data values for clinical 
malaria cases. The inability of health workers to establish 
differential diagnosis for persons with malaria-test nega-
tive results might explain continued reporting of clinical 
malaria cases despite availability of malaria diagnostics 
[35]. Sustained availability of malaria diagnostics in all 
health facilities, parasitological diagnosis of malaria for 
all persons before treatment and capacity to appropri-
ately manage malaria test-negative patients are all criti-
cal components required to achieve the national target 
of 100% parasitological diagnosis of all persons with sus-
pected malaria presenting to a health provider in Kenya 
[23].
Although 90% of pregnant women make at least one 
ANC visit, only 70% of public sector facilities reported 
new ANC visit [37, 42]. The indicator, attendance at first 
ANC visit, is more frequently reported compared to 
other malaria indicators due, in part, to its widespread 
use as a tracer indicator in the WHO data quality assess-
ment framework [4, 43]. Attendance at first ANC visit, a 
national indicator, and IPTp 1 and IPTp 2, sub-national 
indicators, both showed increasing trends for report-
ing completeness from 2011 to 2014. However, in 2015, 
the percentage of public-sector facilities reporting IPTp 
1 and 2 declined by 19 percentage points compared to 
2014 despite the continued positive trend in attendance 
at first ANC visit reporting. It seems unlikely that facili-
ties would continue reporting attendance at first ANC 
visit but stop reporting IPTp 1 and 2 doses. Kenya experi-
enced country-wide stock-outs of sulfadoxine–pyrimeth-
amine in 2015, which were reported in national malaria 
surveillance bulletins and biennial quality-of-care sur-
vey [41]. Thus, the decline in reporting completeness 
of IPTp 1 and 2 doses seems more likely a reflection of 
interrupted service delivery due to lack of sulfadoxine–
pyrimethamine at the facility-level in 2015; data inter-
pretation would be more direct if facilities had reported 
‘zeros’ for IPTp doses.
The overall gains in reporting completeness of malaria 
data indicators in Kenya could be attributed, in part, to 
technical expertise from the Ministry of Health and 
strong partnerships with development, technical and 
implementing partners, who have contributed financial, 
technical and operational support [23]. Similar exper-
tise and partnerships are being developed at the county 
level, which have advanced rapidly since 2013. The strong 
national malaria strategic plan framework has led to 
robust monitoring and evaluation of malaria indica-
tors such as quarterly national malaria surveillance bul-
letins since 2012, biennial quality-of-care surveys since 
2010, and regular national household surveys [23]. For 
example, quarterly national malaria surveillance bulle-
tins highlight counties with reporting rates below 60% 
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[25–31, 44–46]. Regular data reviews and technical 
working groups at both the national and county levels 
monitor the progress of key malaria indicators and sup-
port is provided to counties to increase reporting rates to 
>80% to ensure that the data reported nationally is both 
generalizable and representative.
There were important gaps in the reporting system as a 
result of programmatic limitations, which were reflected 
in the analysis. The lack of data for malaria tests per-
formed and test-positive results was a major gap iden-
tified in DHIS2. Prior to the national introduction of 
malaria RDTs, malaria testing was predominantly per-
formed by microscopy and reported on a quarterly basis 
through a parallel laboratory management information 
system. Following the national introduction of malaria 
RDTs, new data forms to capture persons with suspected 
malaria tested by RDTs and microscopy and results by 
type of test were developed and integrated into DHIS2 in 
2014. However, the transition to reporting malaria-test 
data through DHIS2 has been slow as shown by the pau-
city of data reported in 2015.
The overarching goal of the Kenya national malaria 
strategy is elimination [23, 47]. Zero-reporting is a key 
surveillance strategy successfully used to increase sen-
sitivity in the polio eradication programme, which was 
later extended to other disease elimination and eradica-
tion programmes [48]. Kenya should consider adopting 
a zero-reporting policy and instituting DHIS2 system-
based solutions along with revised training and support 
modules to improve surveillance. High reporting com-
pleteness for malaria indicators, including zero-reporting, 
could provide sufficient data to determine when sub-
national regions and the country meet the required WHO 
threshold (i.e., slide positivity rate of <5% during the peak 
malaria season) to move to the malaria pre-elimination 
phase [49]. Finally, due to the very large number of obser-
vations included in the analysis (i.e., all health facilities), 
very small changes over time, which were statistically sig-
nificant, may not necessarily indicate sustained systematic 
improvement. Broader contextual changes were therefore 
considered in the interpretation of the results.
Conclusions
There have been sustained improvements in the com-
pleteness of data reporting for most key malaria indi-
cators since the adoption of DHIS2 in Kenya in 2011. 
However, major gaps were identified including the lack 
of data reported for malaria tests performed, no zero-
reporting and overall low reporting from private health 
facilities. Ongoing efforts to integrate malaria-test 
data into DHIS2 should improve indicator availability 
and help determine Kenya’s progress towards meeting 
national and international targets. A package of proven 
DHIS2 implementation interventions and performance-
based incentives should be considered to improve pri-
vate-sector data reporting.
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